MECHANICAL LOWBACK PAIN. Biomechanical lesion, unspecified
Conditions
Interventions
Intervention 1: intervention group: using Celecoxib capsule 100 mg daily and using tDCS device for 5 days, 20 minutes. Intervention 2: control group: using Celecoxib capsule 100 mg daily and using s
Treatment - Other
intervention group: using Celecoxib capsule 100 mg daily and using tDCS device for 5 days, 20 minutes
control group: using Celecoxib capsule 100 mg daily and using sham status of tDCS device for 5 days, 20 minutes
Sponsors
Vice Chancellor for research of Aja University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: low back pain history for 3 months; age 18-55. exclusion criteria: history of severe trauma to the low back; history of cancer; history of steroid use; severe weight loss; significant morning stiffness; signs of infection such as fever; night sweats; peripheral joint involvement; positive family history of rheumatic diseases; non-mechanical nature of pain (night pain, unrelated to activity); progressive muscle weakness; neurological defects; incontinence of urine and feces; evidence of spinal cord injury; radiculopathy; immunodeficiency disease; history of spinal surgery in the past year; neurodegenerative diseases; mental illness; pregnancy; dizziness; headaches; ear pain increased continuously.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disability intensity. Timepoint: before intervention, imidiatly after intervention, 1 month after intervention, 3 month intervention. Method of measurement: OSWESTRY quastionaire.;Pain intensity. Timepoint: before intervention, imidiatly after intervention, 1 month after intervention, 3 month intervention. Method of measurement: VAS quastionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamane Seddighi
AJA university of Medical Sciences
Outcome results
None listed